New insights from murine lupus: Disassociation of autoimmunity and end organ damage and the role of T cells

Current Opinion in Rheumatology

Volumn 17, Issue 5, 2005, Pages 523-528

  Bagavant, Harini ^a   Fu, Shu Man ^a,b  

^a UNIVERSITY OF VIRGINIA   (United States)

^b UNIVERSITY OF VIRGINIA   (United States)

Author keywords

Acute and chronic lupus glomerulonephritis; Lupus susceptibility genes; NZM2328 mice; Renal failure; Systemic lupus erythematosus

Indexed keywords

AUTOANTIBODY; CYTOPLASM PROTEIN; DNA ANTIBODY; DOUBLE STRANDED DNA; HISTONE; KIDNEY ANTIGEN; LA ANTIGEN; NUCLEAR PROTEIN; PROTEIN SM;

ACUTE GLOMERULONEPHRITIS; ANTIBODY PRODUCTION; ANTIBODY SPECIFICITY; B LYMPHOCYTE; CHROMATIN; CHRONIC GLOMERULONEPHRITIS; GENE INTERACTION; GENE MAPPING; GENETIC REGULATION; GENETIC SUSCEPTIBILITY; HUMAN; IMMUNE COMPLEX DISEASE; IMMUNOLOGICAL TOLERANCE; IMMUNOREACTIVITY; IMMUNOREGULATION; INNATE IMMUNITY; LUPUS ERYTHEMATOSUS NEPHRITIS; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; REVIEW; SYSTEMIC LUPUS ERYTHEMATOSUS; T LYMPHOCYTE;

ANIMALS; AUTOIMMUNITY; DISEASE MODELS, ANIMAL; HUMANS; LUPUS ERYTHEMATOSUS, SYSTEMIC; MICE; T-LYMPHOCYTES;

EID: 27344457161     PISSN: 10408711     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.bor.0000169361.23325.1e     Document Type: Review

References (57)

1. Agnello V, Koffler D, Kunkel HG. Immune complex systems in the nephritis of systemic lupus erythematosus. Kidney Int 1973; 3:90-99.
2. Koffler D, Carr R, Agnello V, et al. Antibodies to polynucleotides in human sera: antigenic specificity and relation to disease. J Exp Med 1971; 134:294-312.
3. Zielinski CE, Jacob SN, Bouzahzah F, et al. Naive CD4+ T cells from lupus-prone Fas-intact MRL mice display TCR-mediated hyperproliferation due to intrinsic threshold defects in activation. J Immunol 2005; 174:5100-5109. This study uses transgenic T cells from lupus mice and non-lupus, H-2-matched control strains to compare calcium signaling and proliferative responses to the cognate pigeon cytochrome c T-cell epitope and its modified lower affinity peptides. The results demonstrate intrinsic hyper-responsiveness in T cells from lupus backgrounds.
4. Vratsanos GS, Jung S, Park YM, Craft J. CD4(+) T cells from lupus-prone mice are hyperresponsive to T cell receptor engagement with low and high affinity peptide antigens: a model to explain spontaneous T cell activation in lupus. J Exp Med 2001; 193:329-337.
5. Kong PL, Odegard JM, Bouzahzah F, et al. Intrinsic T cell defects in systemic autoimmunity. Ann N Y Acad Sci 2003; 987:60-67.
6. Yurasov S, Wardemann H, Hammersen J, et al. Defective B cell tolerance checkpoints in systemic lupus erythematosus. J Exp Med 2005; 201:703-711. This article describes an important method for study of B-cell repertoires in humans.
7. Grimaldi CM, Hicks R, Diamond B. B cell selection and susceptibility to autoimmunity. J Immunol 2005; 174:1775-1781. A recent review of literature on role of B-cell function, repertoire, and autoimmune disease.
8. Rosen A, Casciola-Rosen L. Altered autoantigen structure in Sjogren's syndrome: implications for the pathogenesis of autoimmune tissue damage. Crit Rev Oral Biol Med 2004; 15:156-164.
9. Lawson BR, Baccala R, Song J, et al. Deficiency of the cyclin kinase inhibitor p21 (WAF-1/CIP-1) promotes apoptosis of activated/memory T cells and inhibits spontaneous systemic autoimmunity. J Exp Med 2004; 199:547-557. This study is an example of mutation in a single molecule affecting immune function, resulting in lupus-like autoimmunity.
10. Bolland S, Ravetch JV. Spontaneous autoimmune disease in Fc(gamma)RIIB-deficient mice results from strain-specific epistasis. Immunity 2000; 13:277-285.
11. McGaha TL, Sorrentino B, Ravetch JV. Restoration of tolerance in lupus by targeted inhibitory receptor expression. Science 2005; 307:590-593. FcγRIIB is an important regulator of immune function. Increased expression of FcγRIIB on B cells in lupus mice can reduce spontaneous disease induction.
12. Pollard KM, Arnush M, Hultman P, Kono DH. Costimulation requirements of induced murine systemic autoimmune disease. J Immunol 2004; 173:5880-5887. Mice deficient in molecules important for co-stimulation of T cells, CD28, ICAM, and CD40L, were studied for susceptibility to disease induction in a model of heavy metal mercury-induced SLE.
13. Pollard KM, Hultman P, Kono DH. Using single-gene deletions to identify checkpoints in the progression of systemic autoimmunity. Ann N Y Acad Sci 2003; 987:236-239.
14. Peng SL, Moslehi J, Craft J. Roles of interferon-gamma and interleukin-4 in murine lupus. J Clin Invest 1997; 99:1936-1946.
15. Singh RR, Saxena V, Zang S, et al. Differential contribution of IL-4 and STAT6 vs STAT4 to the development of lupus nephritis. J Immunol 2003; 170:4818-4825.
16. Hron JD, Peng SL. Type I IFN protects against murine lupus. J Immunol 2004; 173:2134-2142. Upregulation of interferons and interferon-regulated genes has been investigated as an important marker of human lupus. In this study, congenic mice deficient in interferon receptors were generated, and the effect of interferon-mediated signaling on SLE was studied.
17. Santiago-Raber ML, Laporte C, Reininger L, Izui S. Genetic basis of murine lupus. Autoimmun Rev 2004; 3:33-39. An excellent review listing the different genetic loci in spontaneous murine models of SLE.
18. Rudofsky UH, Evans BD, Balaban SL, et al. Differences in expression of lupus nephritis in New Zealand Mixed H-2z homozygous inbred strains of mice derived from New Zealand Black and New Zealand White mice: origins and initial characterization. Lab Invest 1993; 68:419-426.
19. Waters ST, Fu SM, Gaskin F, et al. NZM2328: a new mouse model of systemic lupus erythematosus with unique genetic susceptibility loci. Clin Immunol 2001; 100:372-383.
20. Waters ST, McDuffie M, Bagavant H, et al. Breaking tolerance to double stranded DNA, nucleosome, and other nuclear antigens is not required for the pathogenesis of lupus glomerulonephritis. J Exp Med 2004; 199:255-264. This study uses congenic mice, confirming the genetic contributions to different lupus phenotypes identified in the NZM2328 background. It is the first clear genetic dissociation of lupus autoantibodies from fatal renal disease.
21. Morel L, Rudofsky UH, Longmate JA, et al. Polygenic control of susceptibility to murine systemic lupus erythematosus. Immunity 1994; 1:219-229.
22. Morel L, Mohan C, Yu Y, et al. Functional dissection of systemic lupus erythematosus using congenic mouse strains. J Immunol 1997; 158:6019-6028.
23. Morel L, Yu Y, Blenman KR, et al. Production of congenic mouse strains carrying genomic intervals containing SLE-susceptibility genes derived from the SLE-prone NZM2410 strain. Mamm Genome 1996; 7:335-339.
24. Mohan C, Morel L, Yang P, et al. Genetic dissection of lupus pathogenesis: a recipe for nephrophilic autoantibodies. J Clin Invest 1999; 103:1685-1695.
25. Mohan C, Alas E, Morel L, et al. Genetic dissection of SLE pathogenesis: Sle 1 on murine chromosome 1 leads to a selective loss of tolerance to H2A/H2B/DNA subnucleosomes. J Clin Invest 1998; 101:1362-1372.
26. Mohan C, Morel L, Yang P, Wakeland EK. Genetic dissection of systemic lupus erythematosus pathogenesis: Sle2 on murine chromosome 4 leads to B cell hyperactivity. J Immunol 1997; 159:454-465.
27. Mohan C, Yu Y, Morel L, et al. Genetic dissection of Sle pathogenesis: Sle3 on murine chromosome 7 impacts T cell activation, differentiation, and cell death. J Immunol 1999; 162:6492-6502.
28. Sobel ES, Mohan C, Morel L, et al. Genetic dissection of SLE pathogenesis: adoptive transfer of Sle 1 mediates the loss of tolerance by bone marrow-derived B cells. J Immunol 1999; 162:2415-2421.
29. Morel L, Blenman KR, Croker BP, Wakeland EK. The major murine systemic lupus erythematosus susceptibility locus, Sle 1, is a cluster of functionally related genes. Proc Natl Acad Sci U S A 2001; 98:1787-1792.
30. Wandstrat AE, Nguyen C, Limaye N, et al. Association of extensive polymorphisms in the SLAM/CD2 gene cluster with murine lupus. Immunity 2004; 21:769-780. This article describes an approach for identification of candidate genes for lupus susceptibility in NZM2410 mice. This study shows correlation of autoimmune hyperresponsiveness with the SLAM/CD2 cluster of genes on chromosome 1.
31. Xie S, Chang S, Yang P, et al. Genetic contributions of nonautoimmune SWR mice toward lupus nephritis. J Immunol 2001; 167:7141-7149.
32. Xie S, Chang SH, Sedrak P, et al. Dominant NZB contributions to lupus in the (SWR × NZB)F1 model. Genes Immun 2002; 3(suppl 1):S13-S20.
33. Xie S, Li L, Chang S, et al. Genetic origin of lupus in NZB/SWR hybrids: lessons from an intercross study. Arthritis Rheum 2005; 52:659-667. Lupus susceptibility is dictated by epistatic interactions between genes from lupus-susceptible and resistant parental mouse strains. Mapping of the genetic contributions from parental non-lupus SWR mice in the (SWRxNZB) F1 mice is described.
34. Rigby RJ, Rozzo SJ, Boyle JJ, et al. New loci from New Zealand Black and New Zealand White mice on chromosomes 4 and 12 contribute to lupus-like disease in the context of BALB/c. J Immunol 2004; 172:4609-4617.
35. Rigby RJ, Rozzo SJ, Gill H, et al. A novel locus regulates both retroviral glycoprotein 70 and anti-glycoprotein 70 antibody production in New Zealand mice when crossed with BALB/c. J Immunol 2004; 172:5078-5085.
36. Shi X, Xie C, Kreska D, et al. Genetic dissection of SLE: SLE1 and FAS impact alternate pathways leading to lymphoproliferative autoimmunity. J Exp Med 2002; 196:281-292.
37. Bolland S, Yim YS, Tus K, et al. Genetic modifiers of systemic lupus erythematosus in FcgammaRIIB(-/-) mice. J Exp Med 2002; 195:1167-1174.
38. Waldman M, Madaio MP. Pathogenic autoantibodies in lupus nephritis. Lupus 2005; 14:19-24. An excellent review on the current understanding of lupus autoantibodies in renal disease.
39. Liang Z, Xie C, Chen C, et al. Pathogenic profiles and molecular signatures of antinuclear autoantibodies rescued from NZM2410 lupus mice. J Exp Med 2004; 199:381-398.
40. Sekine H, Watanabe H, Gilkeson GS. Enrichment of anti-glomerular antigen antibody-producing cells in the kidneys of MRL/MpJ-Fas(lpr) mice. J Immunol 2004; 172:3913-3921.
41. Mannik M, Merrill CE, Stamps LD, Wener MH. Multiple autoantibodies form the glomerular immune deposits in patients with systemic lupus erythematosus. J Rheumatol 2003; 30:1495-1504.
42. Arbuckle MR, McClain MT, Rubertone MV, et al. Development of autoantibodies before the clinical onset of systemic lupus erythematosus. N Engl J Med 2003; 349:1526-1533.
43. Fu SM, Castillo JD, Deshmukh US, et al. Autoantibodies and glomerulonephritis in systemic lupus erythematosus. Lupus 2003; 12:175-180.
44. Deshmukh US, Gaskin F, Lewis JE, et al. Mechanisms of autoantibody diversification to SLE-related autoantigens. Ann N Y Acad Sci 2003; 987:91-98.
45. Deshmukh US, Kannapell CC, Fu SM. Immune responses to small nuclear ribonucleoproteins: antigen-dependent distinct B cell epitope spreading patterns in mice immunized with recombinant polypeptides of small nuclear ribonucleoproteins. J Immunol 2002; 168:5326-5332.
46. Deshmukh US, Lewis JE, Gaskin F, et al. Ro60 peptides induce antibodies to similar epitopes shared among lupus-related autoantigens. J Immunol 2000; 164:6655-6661.
47. Deshmukh US, Lewis JE, Gaskin F, et al. Immune responses to Ro60 and its peptides in mice, I: the nature of the immunogen and endogenous autoantigen determine the specificities of the induced autoantibodies. J Exp Med 1999; 189:531-540.
48. Bagavant H, Thompson C, Ohno K, et al. Differential effect of neonatal thymectomy on systemic and organ-specific autoimmune disease. Int Immunol 2002; 14:1397-1406.
49. Chan OT, Hannum LG, Haberman AM, et al. A novel mouse with B cells but lacking serum antibody reveals an antibody-independent role for B cells in murine lupus. J Exp Med 1999; 189:1639-1648.
50. Bagavant H, Deshmukh US, Gaskin F, Fu SM. Lupus glomerulonephritis revisited 2004: autoimmunity and end-organ damage. Scand J Immunol 2004; 60:52-63.
51. Schiffer L, Sinha J, Wang X, et al. Short term administration of co-stimulatory blockade and cyclophosphamide induces remission of systemic lupus erythematosus nephritis in NZB/W F1 mice by a mechanism downstream of renal immune complex deposition. J Immunol 2003; 171:489-497.
52. Bagavant H, Tung KSK, Sung SS-J, Fu SM. Pathogenesis of chronic lupus glomerulonephritis: a role for B and T cells. Clin Invest Med 2004; 27:181C.
53. Massengill SF, Goodenow MM, Sleasman JW. SLE nephritis is associated with an oligoclonal expansion of intrarenal T cells. Am J Kidney Dis 1998; 31:418-426.
54. Bloom RD, O'Connor T, Cizman B, et al. Intrathymic kidney cells delay the onset of lupus nephritis in MRL-lpr/lpr mice. Int Immunol 2002; 14:867-871.
55. Xie C, Sharma R, Wang H, et al. Strain distribution pattern of susceptibility to immune-mediated nephritis. J Immunol 2004; 172:5047-5055. In this study, immune complex nephritis was induced in different mouse strains by immunization with rabbit immunoglobulin followed by injection of rabbit anti-glomerular basement membrane antibody. The results showed that despite a robust immune response, renal disease was strain-dependent. Thus, intrinsic end-organ susceptibility dictates renal disease.
56. Xie C, Zhou XJ, Liu X, Mohan C. Enhanced susceptibility to end-organ disease in the lupus-facilitating NZW mouse strain. Arthritis Rheum 2003; 48:1080-1092.
57. Bagavant H, Tung KSK. Neonatal thymectomy in a murine model of systemic lupus erythematosus: role of regulatory T cells in systemic autoimmune disease [abstract]. Arthritis Rheum 2004; 50:3590, abstract 1559.